Mounaro

Eli Lilly Plans New $2.5B Manufacturing Site in Germany for Injectable Meds

The German manufacturing site is the latest capital infrastructure move for Eli Lilly, which has already made $11 billion in investments in its global manufacturing capabilities in the past three years. The new site will help Lilly meet strong demand for its diabetes and obesity drugs.

By Frank Vinluan

Physicians

OmniLife Health’s Clinical Workflow Solution Focuses on Complex Care

OmniLife Health's initial focus with its complex care coordination platform is organ transplant care.

Health Tech

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI

HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.